Frank C. Church

Affiliations: 
University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Cell Biology, Pathology, Oncology
Google:
"Frank Church"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Reuland CJ, Church FC. (2020) Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's disease. Medical Hypotheses. 138: 109602
Serebruany VL, Kim MH, Kim SJ, et al. (2017) Contents Vol. 136, 2017 The Cardiology. 136
Antoniak S, Cardenas JC, Buczek LJ, et al. (2016) Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation. Cardiology. 136: 258-268
Cardenas JC, Aleman MM, Wang JG, et al. (2013) Murine models do not recapitulate the pathophysiology of age-related venous thrombosis in humans. Journal of Thrombosis and Haemostasis : Jth. 11: 990-2
Wang JG, Geddings JE, Aleman MM, et al. (2012) Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood. 119: 5543-52
Carter JC, Church FC. (2012) Mature breast adipocytes promote breast cancer cell motility. Experimental and Molecular Pathology. 92: 312-7
Bompiani KM, Monroe DM, Church FC, et al. (2012) A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity. Journal of Thrombosis and Haemostasis : Jth. 10: 870-80
Geddings JE, Wang J, Cardenas JC, et al. (2012) Relationship between tissue factor expression by human pancreatic cancer cells and activation of coagulation and thrombosis in a mouse model. Journal of Clinical Oncology. 30
Wang J, Gambone J, Aleman M, et al. (2012) Human pancreatic cancer cell tissue factor activates coagulation in a mousemodel Thrombosis Research. 129: S171
Carter JC, Church FC. (2011) Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator System. Journal of Oncology. 2011: 594258
See more...